VOLUME 15, ISSUE 4 / FEBRUARY 2023
Technology Evaluation
APRIL 2023
Single-analyte biomarker assays for pharmacodynamic or safety assessment during biotherapeutic development
- Ellen Williams
- Pages:193–195
- Published Online:11 April 2023
Preliminary Communication
APRIL 2023
Determination of asundexian and its metabolite M-10 in human plasma by LC–MS/MS
- Lukas Fiebig,
- Sabine Helmes,
- Michael Kaiser &
- Daniel Werner
- Pages:197–206
- Published Online:11 April 2023
Preliminary Communication
MARCH 2023
Multi-laboratory evaluation of immunoaffinity LC–MS-based glucagon-like peptide-1 assay
- Rika Ishikawa,
- Kosuke Saito
, - Hidehisa Tachiki,
- Ryoya Goda,
- Koji Arai,
- Hisao Shimizu ,
- Tomohiro Andou ,
- Kentaro Takahara,
- Hitoshi Uchiyama ,
- Shin-ichiro Nitta,
- Masaaki Kakehi,
- Kozo Hayashi,
- … See all authors
- Pages:207–218
- Published Online:24 March 2023
Research Article
APRIL 2023
Development of a sensitive HPLC method with fluorescence detection for the determination of motilin in human plasma
- Sakine Atila Karaca ,
- Tuncer Temel &
- Duygu Yeniceli Uğur
- Pages:219–229
- Published Online:4 April 2023
Research Article
APRIL 2023
Comparison of pharmacokinetic profiles in hypoalbuminemia and healthy rats after parecoxib sodium injection by LC–MS/MS
- Zhiyong Zhang,
- Dengyun Fan,
- Liya Zheng,
- Haoran Li,
- Xiaoxu Zhang &
- Xiuling Yang
- Pages:231–243
- Published Online:6 April 2023